To investigate the effect of pharmacological inhibition of LRRK2 on the development and spread of tau pathology, we used an established seed-based model of tauopathy that induces the misfolding of endogenous tau into hyperphosphorylated tau inclusions following injection of AD brain-derived tau into mice [24]. This evidence concerns the gene MAPT and Alzheimer disease.